These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6662041)

  • 21. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of neferine on transmembrane potentials of guinea pig myocardium].
    Li GR; Li XG; Lü FH
    Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):406-10. PubMed ID: 2618727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of dauricine on action potentials and slow inward currents of guinea pig ventricular papillary muscles].
    Li SN; Zhang KY
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):535-7. PubMed ID: 1338863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The importance of hydrophobic groups for the antiarrhythmic results of alkylated sparteine].
    Engelmann K; Raake W; Petter A
    Arzneimittelforschung; 1974 May; 24(5):795-61. PubMed ID: 4408134
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiarrhythmic drugs.
    Awalt CH
    Clin Anesth; 1974; 10(1):167-83. PubMed ID: 4598995
    [No Abstract]   [Full Text] [Related]  

  • 26. Class III antiarrhythmic effects of ceruloplasmin on rat heart.
    Atanasiu R; Gouin L; Mateescu MA; Cardinal R; Nadeau R
    Can J Physiol Pharmacol; 1996 Jun; 74(6):652-6. PubMed ID: 8909775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antiarrhythmic drugs in the isolated papillary muscle preparation of the guinea-pig.
    Bandolet J; Rump S
    Pol J Pharmacol Pharm; 1989; 41(6):519-25. PubMed ID: 2485901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antiarrhythmic effect of ethyl acetate extract from Chrysanthemum Morifolium Ramat on rats].
    ZHANG W; YE ZG; CUI J; QIU SF; XU WH; WANG HP; QIAN LB; JIANG HD; XIA Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):377-82. PubMed ID: 19693975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of dauricine on slow action potentials in myocardium].
    Zong XG; Jiang MX
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):241-5. PubMed ID: 2088000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-arrhythmic action of cimetidine].
    Fu SX; Li YS
    Zhongguo Yao Li Xue Bao; 1983 Jun; 4(2):106-10. PubMed ID: 6225295
    [No Abstract]   [Full Text] [Related]  

  • 34. Electrophysiologic effects of asocainol, a new antiarrhythmic agent with predominant class I action.
    Thale J; Gülker H; Hagemense B; Rose D; Haverkamp W; Frenking B
    Arzneimittelforschung; 1987 Jan; 37(1):14-6. PubMed ID: 3566851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antiarrhythmic and analgesic drugs on the effective refractory period of guinea-pig isolated atria and ventricular strips.
    Rashid S; Waterfall JF
    J Pharm Pharmacol; 1979 Jun; 31(6):411-2. PubMed ID: 39146
    [No Abstract]   [Full Text] [Related]  

  • 36. Subgroups of class 1 antiarrhythmic drugs.
    Vaughan Williams EM
    Eur Heart J; 1984 Feb; 5(2):96-8. PubMed ID: 6373262
    [No Abstract]   [Full Text] [Related]  

  • 37. Pros and cons of drugs that prolong ventricular refractoriness.
    Brachmann J; Beyer T; Schöls W; Schmitt C; Montero M; Knollmann W; Hilbel T; Kübler W
    Eur Heart J; 1992 Nov; 13 Suppl F():19-22. PubMed ID: 1478219
    [No Abstract]   [Full Text] [Related]  

  • 38. [Progress of cardiovascular pharmacologic study on berbamine].
    Guo ZB; Fu JG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):765-8. PubMed ID: 16152843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of prolyl-valine on electrical activities of rat hearts in situ and its antiarrhythmic action (author's transl)].
    Liu TF; Wei JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Dec; 9(4):311-3. PubMed ID: 7341201
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of cardiac muscle of two drugs related to amiodarone, L8040 and L8462.
    Vaughan Williams EM; Polster P
    Eur J Pharmacol; 1974 Feb; 25(2):241-7. PubMed ID: 4435026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.